Education
About Us
Working with TipRanks
Follow Us
Immunocore Holdings (IMCR)
NASDAQ:IMCR
Imc-P115c
Cancer, Hla-A*02:01-Positive, Prame Positive
Phase I
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
Aug 26, 2025
―
Imc-R117c, Chemotherapy Drug, Kinase Inhibitor, Antiangiogenic Agent, Monoclonal Antibody
Cancer, Hla-A*02:01-Positive
Phase I/II
Recruiting
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
Feb 05, 2025
―
Nivolumab, Nivolumab + Relatlimab, Brenetafusp
Advanced Melanoma
Phase III
Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Oct 19, 2023
―
Tebentafusp, Tebentafusp With Pembrolizumab, Investigators Choice
Advanced Melanoma
Phase III
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Aug 26, 2022
―
Brenetafusp, Brenetafusp And Pembrolizumab, Brenetafusp And Chemotherapy, Brenetafusp And Monoclonal Antibodies And Chemotherapy, Brenetafusp And Tebentafusp, Brenetafusp And Bevacizumab, Brenetafusp And Kinase Inhibitors
Select Advanced Solid Tumors
Phase I/II
Recruiting
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Jan 30, 2020
―
Pembrolizumab, Ipilimumab, Dacarbazine, Imcgp100
Uveal Melanoma
Phase II
Active Not Recruiting
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Feb 14, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Immunocore Holdings (IMCR) have in its pipeline
IMCR is currently developing the following drugs: Imc-P115c, Imc-R117c, Chemotherapy Drug, Kinase Inhibitor, Antiangiogenic Agent, Monoclonal Antibody, Nivolumab, Nivolumab + Relatlimab, Brenetafusp. These drug candidates are in various stages of clinical development as the company works toward FDA approval.